Introduction: Who Should Undergo Diagnostics and When
Many people with peripheral arterial occlusive disease don’t realize they have it until symptoms become hard to ignore. This condition, which affects the arteries supplying blood to your legs, often develops quietly over years. Understanding when to seek diagnostic testing is the first step toward getting the care you need.
You should consider getting checked if you experience leg pain or cramping that starts when you walk or exercise and stops when you rest. This pain, known as intermittent claudication, happens because narrowed arteries can’t deliver enough blood to your leg muscles during activity. The discomfort typically fades within a few minutes of resting, only to return when you start moving again. However, not everyone with this disease has obvious symptoms. In fact, about 40% of people with peripheral arterial occlusive disease have no leg symptoms at all, while another 50% experience leg discomfort that doesn’t fit the classic pattern.[1][2]
Certain groups of people should be especially alert to the possibility of this condition. If you’re over 65, you’re at higher risk simply because of age. The disease becomes increasingly common as people get older, affecting nearly half of those 85 and above. But age isn’t the only factor. If you’re younger but have diabetes, high blood pressure, high cholesterol, or if you smoke or used to smoke, you should also be proactive about screening. People with a family history of atherosclerosis—the buildup of fatty deposits in arteries—also face increased risk.[2][3][4]
It’s important to seek medical attention if you notice other warning signs beyond leg pain. These include coldness in your lower leg or foot, changes in skin color (such as paleness or a bluish tint), slow-growing toenails, hair loss on your legs and feet, or sores on your feet or legs that won’t heal. Some men may also experience erectile dysfunction when arteries in the pelvic area are affected. These symptoms suggest that blood flow is significantly reduced and needs immediate evaluation.[1][5]
Many people mistakenly believe that leg pain with walking is just a normal part of aging. It’s not. If you experience recurring leg pain when exercising or moving around, it’s worth seeing your doctor for evaluation. The good news is that peripheral arterial occlusive disease can be diagnosed with simple, painless tests. Early detection means you can start treatment before complications develop, potentially avoiding surgery and protecting your legs from serious damage.[9][14]
Diagnostic Methods: How Doctors Identify the Disease
Diagnosing peripheral arterial occlusive disease begins with a thorough conversation with your doctor about your symptoms and medical history. Your healthcare provider will ask about any leg pain or discomfort you experience, especially during physical activity. They’ll also want to know about your smoking history, whether you have diabetes or high blood pressure, and if anyone in your family has had heart or blood vessel problems. This background information helps your doctor understand your risk level and guides the diagnostic process.[11]
The physical examination is a crucial part of diagnosis. Your doctor will check the pulses in your legs and feet by feeling for them with their fingers. When peripheral arterial occlusive disease is present, these pulses may feel weak or be completely absent. The examination includes checking pulses from your abdominal area all the way down to your feet, including the femoral arteries in your groin, the popliteal arteries behind your knees, and the arteries in your ankles and feet. Your doctor will also listen with a stethoscope for sounds called bruits—whooshing noises that indicate turbulent blood flow through narrowed arteries. If pulses can’t be felt, your doctor may use a handheld Doppler device, which uses sound waves to detect blood flow.[10][11]
The most common and useful initial test is the ankle-brachial index, or ABI. This simple, painless test compares the blood pressure in your ankle to the blood pressure in your arm. To perform it, a healthcare professional places blood pressure cuffs on your arms and ankles and measures the pressure in each location. The ankle pressure is then divided by the arm pressure to get a ratio. A normal ABI ranges from 0.9 to 1.1. If your ABI is less than 0.9, it suggests you have peripheral arterial occlusive disease. The lower the number, the more severe the blockage. For example, an ABI below 0.5 indicates severe disease. This test is so valuable because it’s non-invasive, quick, and can be done right in your doctor’s office.[5][10][11][15]
Sometimes, if you have symptoms of leg pain with exercise but your resting ABI is normal, your doctor may recommend an exercise ABI test. This involves measuring your ankle and arm blood pressure before and immediately after you walk on a treadmill. In people with peripheral arterial occlusive disease, the ABI often drops significantly after exercise because the narrowed arteries can’t keep up with the increased demand for blood during activity. This test helps identify cases that might otherwise be missed.[11][15]
Blood tests don’t directly diagnose peripheral arterial occlusive disease, but they help identify conditions that increase your risk or may be contributing to the problem. Your doctor will likely order tests to check your cholesterol levels, blood sugar (to screen for diabetes), and kidney function. High cholesterol and high blood sugar both contribute to the buildup of plaque in arteries. These tests also help guide treatment decisions, as managing these conditions is an important part of preventing the disease from getting worse.[11]
If your ABI or other initial tests suggest you have peripheral arterial occlusive disease, your doctor may recommend imaging tests to see exactly where and how severely your arteries are blocked. Ultrasound is often the next step. This painless test uses sound waves to create pictures of blood flow through your arteries. A special type called Doppler ultrasound can show where arteries are narrowed or blocked. The technician moves a device over your legs, and images appear on a screen showing how blood is flowing. Ultrasound is safe, doesn’t involve radiation or needles, and provides valuable information about the location and severity of blockages.[11]
More detailed imaging may be needed if your doctor is considering a procedure to open blocked arteries. Angiography is considered the gold standard for seeing exactly where blockages are located and how severe they are. During this test, a doctor injects a special dye into your blood vessels through a thin tube called a catheter. The dye shows up on X-ray images, creating a detailed map of your arteries and revealing any narrow or blocked areas. Angiography is usually reserved for situations where a treatment procedure, such as angioplasty or surgery, is being planned, because it’s more invasive than other imaging methods.[10][11]
Two other imaging options are computed tomography angiography (CTA) and magnetic resonance angiography (MRA). Both create detailed three-dimensional pictures of your arteries. CTA uses X-rays and a computer to build images, while MRA uses magnets and radio waves instead of radiation. Both tests require injection of a contrast dye to make blood vessels visible. These imaging methods are useful for planning treatment because they show the anatomy of your blood vessels in great detail, helping doctors decide on the best approach to restore blood flow.[10][11]
Diagnostics for Clinical Trial Qualification
When researchers study new treatments for peripheral arterial occlusive disease in clinical trials, they need to use standard tests to make sure all participants truly have the condition and can be compared fairly. The ankle-brachial index remains the cornerstone test for determining whether someone qualifies to participate in a clinical trial. Most trials require a confirmed ABI measurement showing that the ratio is below 0.9, which indicates reduced blood flow to the legs. Some studies may have more specific requirements, such as an ABI below a certain threshold (for example, below 0.7) to focus on people with more severe disease.[15]
Clinical trials often use exercise ABI testing as well, particularly when studying treatments for intermittent claudication. This ensures that participants have disease that becomes symptomatic with activity. The trial protocol typically specifies exactly how the treadmill test should be performed—including the speed and incline of the treadmill and how long participants should walk—to standardize the assessment across all study sites.
Imaging tests like ultrasound, CTA, or MRA may also be required as part of the qualification process for clinical trials. These tests document the exact location and extent of arterial blockages before any treatment begins. This baseline information allows researchers to measure whether the experimental treatment improves blood flow and reduces the degree of narrowing in the arteries. Some trials may also require angiography to provide the most detailed pre-treatment pictures of the arteries.
Blood tests are another standard part of clinical trial screening. Researchers measure cholesterol levels, blood sugar, kidney function, and other markers to ensure participants are healthy enough for the study and to rule out other conditions that might interfere with the results. Some trials exclude people with very poorly controlled diabetes or severe kidney disease, for instance, because these conditions could affect how well treatments work or increase the risk of complications.
Documentation of symptoms is also critical. Many trials require participants to keep detailed records of how far they can walk before pain begins, how severe their pain is, and how much the symptoms interfere with daily activities. Some studies use standardized questionnaires to measure quality of life and walking ability. This information helps researchers understand not just whether a treatment improves blood flow on tests, but whether it actually helps people feel better and do more in their everyday lives.






